Contraceptive prevalence, any modern method in Netherlands
Netherlands: Contraceptive prevalence, any modern method was 75.6% in 1993. ▲ Rising
Contraceptive prevalence, any modern method in Netherlands, 1969–1993
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
In 1993, contraceptive prevalence, any modern method in Netherlands stood at 75.6%. That is the highest value across all 5 years on record.
That represents a change of up 2.4% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Netherlands peaked at 75.6% in 1993 and was at its lowest, 41.6%, in 1969.
Netherlands ranks 7th of 113 countries on this measure, in the top 10%.
Contraceptive prevalence, any modern method in Netherlands, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1969 | 41.6% | — |
| 1975 | 69.1% | +66.1% |
| 1982 | 73.8% | +6.8% |
| 1988 | 72.1% | -2.4% |
| 1993 | 75.6% | +4.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1960s | 41.6% | 41.6% | 41.6% | 1 |
| 1970s | 69.1% | 69.1% | 69.1% | 1 |
| 1980s | 72.9% | 72.1% | 73.8% | 2 |
| 1990s | 75.6% | 75.6% | 75.6% | 1 |
Countries ranked near Netherlands
More health data for Netherlands
- Un projection of annual infant deaths, annual growth rate -2.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1866 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.4989 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0239 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5005 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Netherlands?
- Contraceptive prevalence, any modern method in Netherlands was 75.6% in 1993, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Netherlands?
- The highest recorded value was 75.6% in 1993.
- What is the lowest contraceptive prevalence, any modern method recorded in Netherlands?
- The lowest recorded value was 41.6% in 1969.
- How does Netherlands rank for contraceptive prevalence, any modern method?
- Netherlands ranks 7th out of 113 countries with data for 1993.
- Is contraceptive prevalence, any modern method rising or falling in Netherlands?
- Over the last ten years it is up 2.4%. The long-run trend across the full record is rising.
- Where does this Netherlands data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.